Evidence map›Paper›PMID 34114058›Full record

ArticleEuropean radiology2021

Diagnostic performance of single-phase dual-energy CT to differentiate vascular and nonvascular incidental renal lesions on portal venous phase: comparison with CT.

Domenico Mastrodicasa, Martin J Willemink, Nikhil Madhuripan, Ranjit Singh Chima, Amanzo A Ho, Yuqin Ding, Daniele Marin, Bhavik N Patel

Open access · greenAbstract read
In one paragraph

Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dual-Energy CT in Oncologic Imaging.Tomography (Ann Arbor, Mich.) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Domenico MastrodicasaDepartment of Radiology, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA, 94305, USA.ORCID https://orcid.org/0000-0001-8227-0757
Martin J WilleminkDepartment of Radiology, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA, 94305, USA.ORCID https://orcid.org/0000-0002-6991-6557
Nikhil MadhuripanDepartment of Radiology, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA, 94305, USA.
Ranjit Singh ChimaDepartment of Radiology, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA, 94305, USA.
Amanzo A HoDepartment of Radiology, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA, 94305, USA.
Yuqin DingDepartment of Radiology, Duke University Medical Center, 2301 Erwin Rd, Durham, NC, 27710, USA.ORCID https://orcid.org/0000-0003-3511-4705
Daniele MarinDepartment of Radiology, Duke University Medical Center, 2301 Erwin Rd, Durham, NC, 27710, USA.
Bhavik N PatelDepartment of Radiology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA. patel.bhavik@mayo.edu.ORCID https://orcid.org/0000-0001-5157-9903
Stanford University · USDuke Medical Center · USMayo Clinic in Arizona · USShanghai Medical College of Fudan University · CNUniversity of Colorado Hospital · US

Funding

Multi-Disciplinary Training Program in Cardiovascular Imaging at StanfordT32EB009035 · NIBIB · STANFORD UNIVERSITY · PI Koen Nieman, John M. Pauly · 2008 to 2026
$4.3M
NIBIB NIH HHS T32 EB009035
6 · The paper itself

Abstract

objectivesTo determine whether single-phase dual-energy CT (DECT) differentiates vascular and nonvascular renal lesions in the portal venous phase (PVP). Optimal iodine threshold was determined and compared to Hounsfield unit (HU) measurements.

methodsWe retrospectively included 250 patients (266 renal lesions) who underwent a clinically indicated PVP abdominopelvic CT on a rapid-kilovoltage-switching single-source DECT (rsDECT) or a dual-source DECT (dsDECT) scanner. Iodine concentration and HU measurements were calculated by four experienced readers. Diagnostic accuracy was determined using biopsy results and follow-up imaging as reference standard. Area under the curve (AUC) was calculated for each DECT scanner to differentiate vascular from nonvascular lesions and vascular lesions from hemorrhagic/proteinaceous cysts. Univariable and multivariable logistic regression analyses evaluated the association between variables and the presence of vascular lesions.

resultsA normalized iodine concentration threshold of 0.25 mg/mL yielded high accuracy in differentiating vascular and nonvascular lesions (AUC 0.93, p < 0.001), with comparable performance to HU measurements (AUC 0.93). Both iodine concentration and HU measurements were independently associated with vascular lesions when adjusted for age, gender, body mass index, and lesion size (AUC 0.95 and 0.95, respectively). When combined, diagnostic performance was higher (AUC 0.96). Both absolute and normalized iodine concentrations performed better than HU measurements (AUC 0.92 vs. AUC 0.87) in differentiating vascular lesions from hemorrhagic/proteinaceous cysts.

conclusionA single-phase (PVP) DECT scan yields high accuracy to differentiate vascular from nonvascular renal lesions. Iodine concentration showed a slightly higher performance than HU measurements in differentiating vascular lesions from hemorrhagic/proteinaceous cysts. KEY POINTS: • A single-phase dual-energy CT scan in the portal venous phase differentiates vascular from nonvascular renal lesions with high accuracy (AUC 0.93). • When combined, iodine concentration and HU measurements showed the highest diagnostic performance (AUC 0.96) to differentiate vascular from nonvascular renal lesions. • Compared to HU measurements, iodine concentration showed a slightly higher performance in differentiating vascular lesions from hemorrhagic/proteinaceous cysts.

Indexed as

IodineRadiography, Dual-Energy Scanned ProjectionContrast MediaHumansRetrospective StudiesTomography, X-Ray ComputedContrast MediaIodineContrast mediaIodineKidneyKidney neoplasmsRadiography, dual-energy scanned projection

Identifiers

PMID34114058
PMCPMC9282667
OpenAlexW3168980200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.